Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - OSIRIS THERAPEUTICS, INC. | Financial_Report.xls |
| 10-K - 10-K - OSIRIS THERAPEUTICS, INC. | a2223659z10-k.htm |
| EX-10.7 - EX-10.7 - OSIRIS THERAPEUTICS, INC. | a2223659zex-10_7.htm |
| EX-10.9 - EX-10.9 - OSIRIS THERAPEUTICS, INC. | a2223659zex-10_9.htm |
| EX-31.1.1 - EX-31.1.1 - OSIRIS THERAPEUTICS, INC. | a2223659zex-31_11.htm |
| EX-32.1.1 - EX-32.1.1 - OSIRIS THERAPEUTICS, INC. | a2223659zex-32_11.htm |
| EX-31.2.1 - EX-31.2.1 - OSIRIS THERAPEUTICS, INC. | a2223659zex-31_21.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Osiris
Therapeutics, Inc.
Columbia, Maryland
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-148750) and Forms S-8 (No. 333-167652, 333-137953, 333-184838 and 333-199132) of Osiris Therapeutics, Inc. of our reports dated March 20, 2015, relating to the financial statements and financial statement schedule, and the effectiveness of Osiris Therapeutics, Inc.'s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
Bethesda,
Maryland
March 20, 2015
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM